Functional characterization and expression analysis of novel alternative splicing isoforms of Olr1 gene during mouse embryogenesis

Gene

Volumn 491, Issue 1, 2012, Pages 5-12

  Vecchione, Lucia ^a   Diano, Laura ^a   Campagnolo, Luisa ^a   Rocchi, Lucia ^a   Ferrè, Fabrizio ^a   Mehta, Jawahar L ^b   Novelli, Giuseppe ^b,c,d   Amati, Francesca ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d Responsable for National Scientific Habilitation   (Italy)

Author keywords

Alternative splicing; Embryonic development; Expression study; Lox 1; Olr1

Indexed keywords

MEMBRANE PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLR1 GENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; EMBRYONIC DEVELOPMENT; GENE EXPRESSION; HEART; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; SCAVENGER RECEPTORS, CLASS E; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 80055067811     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.09.030     Document Type: Article

References (36)

1. Aoyama T., et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem. J. 1999, 339:177-184.
2. Biocca S., et al. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J. Mol. Cell. Cardiol. 2008, 44:561-570.
3. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2003, 72:291-336.
4. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 2009, 10:741-754.
5. Chen M., Sawamura T. Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1). J. Mol. Cell. Cardiol. 2005, 39:553-561.
6. Claros M.G., von Heijne G. TopPred II: an improved software for membrane protein structure predictions. Comput. Appl. Biosci. 1994, 10:685-686.
7. Cserzö M., Wallin E., Simon I., von Heijne G., Elofsson A. Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. Protein Eng. 1997, 10:673-676.
8. Fletcher R.B., Baker J.C., Harland R.M. FGF8 splice forms mediate early mesoderm and posterior neural tissue formation in Xenopus. Development 2006, 133:1703-1714.
9. Gemel J., Gorry M., Ehrlich G.D., MacArthur C.A. Structure and sequence of human FGF8. Genomics 1996, 35:253-257.
10. Guiraud-Dogan C., et al. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice. Biochim. Biophys. Acta 2007, 1772:1183-1191.
11. Guo Q., Li J.Y. Distinct functions of the major Fgf8 splice form, Fgf8b, before and during mouse gastrulation. Development 2007, 134:2251-2260.
12. Hirokawa T., Boon-Chieng S., Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998, 14:378-379.
13. Hirsch H.A., et al. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010, 17:348-361.
14. Hofmann K., Stoffel W. TMbase - a database of membrane spanning proteins segments. Biol. Chem. Hoppe Seyler 1993, 347:166.
15. Hoshikawa H., Sawamura T., Kakutani M., Aoyama T., Nakamura T., Masaki T. High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1). Biochem. Biophys. Res. Commun. 1998, 245:841-846.
16. Khaidakov M., et al. Oxidized LDL Receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS One 2011, 6:e20277.
17. Knowles J.W., et al. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. BMC Med. Genet. 2008, 9:23.
18. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305:567-580.
19. Kuiper R.P., Schepens M., Thijssen J., Schoenmakers E.F., van Kessel A.G. Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res. 2004, 32:2315-2322.
20. Liu Y., Ray S.K., Yang X.Q., Luntz-Leybman V., Chiu I.M. A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box. J. Biol. Chem. 1998, 273:19269-19276.
21. Lu J., Mitra S., Wang X., Khaidakov M., Mehta J.L. Oxidative stress and lectin-like Ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid. Redox Signal. 2011, 15:2301-2333.
22. Mango R., et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ. Res. 2005, 97:152-158.
23. Mehta J.L., Chen J., Hermonat P.L., Romeo F., Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc. Res. 2006, 69:36-45.
24. Nagase M., Hirose S., Fujita T. Unique repetitive sequence and unexpected regulation of expression of rat endothelial receptor for oxidized low-density lipoprotein (LOX-1). Biochem. J. 1998, 330:1417-1422.
25. Novelli G., Borgiani P., Mango R., Romeo F., Mehta J.L. OLR1 gene and coronary artery disease/acute myocardial infarction: replication in an independently collected sample. Eur. J. Hum. Genet. 2006, 14:894-895.
26. Nugent T., Jones D.T. Transmembrane protein topology prediction using support vector machines. BMC Bioinforma. 2009, 10:159.
27. Ogura S., Kakino A., Sato Y., Fujita Y., Iwamoto S., Otsui K., Yoshimoto R., Sawamura T. Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ. J. 2009, 73:1993-1999.
28. Ohmori R., et al. An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin. Cardiol. 2004, 27:641-644.
29. Olsen S.K., et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 2006, 20:185-198.
30. Revil T., Gaffney D., Dias C., Majewski J., Jerome-Majewska L.A. Alternative splicing is frequent during early embryonic development in mouse. BMC Genomics 2010, 11:399.
31. Rost B., Fariselli P., Casadio R. Topology prediction for helical transmembrane proteins at 86% accuracy. Protein Sci. 1996, 5:1704-1718.
32. Tatsuguchi M., et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem. Biophys. Res. Commun. 2003, 303:247-250.
33. Tusnády G.E., Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001, 17:849-850.
34. Vandenbroucke I.I., Vandesompele J., Paepe A.D., Messiaen L. Quantification of splice variants using real-time PCR. Nucleic Acids Res. 2001, 29. E68.27.
35. Vecchione L., et al. Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2007, 2:147-151.
36. Wilkinson D.G., Nieto M.A. Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts. Methods Enzymol. 1993, 225:361-373.